Hidradenitis Süpürativa: Türkiye Malatya'dan 9 Yıllık Retrospektif Bir Çalışma

Abstract

Objective: Hidradenitis suppurativa (HS) is a chronic, recurrent inflammatory skin disease. Our aim of this study is to review the demographic, clinical characteristics, treatment options of the patients who were being followed up with diagnosis of HS in our hospital during the last 9 years and to make a comparison with the data from other countries. Material and Methods: A total of 59 patients with HS diagnosed in our Dermatology Department between 2010-2019 were evaluated retrospectively. Results: Seventeen (28.8%) of 59 patients were female, 42 (71.2%) were male. The mean age at diagnosis was 31.05±1.61 (minimum / maximum: 14-60). Seventeen patients (28.8%) had stage 1, 26 patients (44.1%) had stage 2 and 16 patients (27.1%) had stage 3 disease. Axilla was the most affected area. Topical agents (topical clindamycin, antiseptic solutions) and oral antibiotics (doxycycline, ciprof loxacin, ampicillin-sulbactam, amoxicillin-clavulanic acid) were the most commonly used treatment options. Treatment resistant eight patients were treated with a biological agent adalimumab. Conclusion: In literature, there are few epidemiological studies related to HS in Turkey. The clinical, demographic and therapeutic data of 59 HS cases in our clinic were summarized. However, we believe that multi-center studies conducted with larger number of patients are needed in order to reach more comprehensive data on this subject.